CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease. [electronic resource]
Producer: 20190628Description: 13526 p. digitalISSN:- 2045-2322
- Animals
- Apoptosis -- drug effects
- CCAAT-Enhancer-Binding Protein-beta -- antagonists & inhibitors
- Cells, Cultured
- Disease Models, Animal
- Dopaminergic Neurons -- cytology
- Humans
- Male
- Mesencephalon -- cytology
- Oxidopamine -- pharmacology
- Parkinson Disease -- metabolism
- Pars Compacta -- drug effects
- RNA Interference
- RNA, Small Interfering -- metabolism
- Rats
- Rats, Wistar
- alpha-Synuclein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.